Zjazd Polskiego Towarzystwa Biochemicznego
on-line journal
Lectures
Sesja plenarna
Sympozjum A
Sympozjum B
Sympozjum C
Sympozjum D
Sympozjum E
Sympozjum F
Sympozjum G
Sympozjum H
Sympozjum I
Sympozjum J
Sympozjum K
Sympozjum L
Sympozjum M
Sympozjum V
Posters
Sesja plenarna
Sympozjum A
Sympozjum B
Sympozjum C
Sympozjum D
Sympozjum E
Sympozjum F
Sympozjum G
Sympozjum H
Sympozjum I
Sympozjum J
Sympozjum K
Sympozjum L
Sympozjum M
Sympozjum V
Timetable
Sesja plenarna
Sympozjum A
Sympozjum B
Sympozjum C
Sympozjum D
Sympozjum E
Sympozjum F
Sympozjum G
Sympozjum H
Sympozjum I
Sympozjum J
Sympozjum K
Sympozjum L
Sympozjum M
Sympozjum V
Downloads
Statistics
Participants
Countries
Institutions
Presentations per country
Symposia attendance
Time
Duration
Type
Presenting person
Title
September 19th, Wednesday
09:30
Sesja 5: Biochemia nowotworów
09:30
00:40:00
Wykład
Grzegorz Bartosz
Oxidative stress and cancer
10:10
00:40:00
Wykład
Katarzyna Piwocka
Aneuploidy and cancer; Bcr-Abl expression leads to compromised mitotic spindle checkpoint promoting chromosomal instability
10:50
00:40:00
Wykład
Andrzej M. Składanowski
From chemoresistance to cancer stem cells: the case of BRCP/ABCG2 half transporter
11:30
Przerwa
12:00
00:40:00
Wykład
Stanisław Szala
Tumor blood vessels – a target for anticancer therapy
12:40
00:20:00
Wykład
Izabela Sacewicz
Influence of DNAzymes to β1 integrin subunit on tumoral neovascularisation
13:00
00:20:00
Wykład
Barbara Krawczyk
Epigenetic therapy - modulation of the effects of nucleoside analogues on methylation and expression of selected tumour suppressor genes by natural compounds in breast cancer cells
13:20
00:20:00
Wykład
Anna Jankowska
Reduction of hCGß gene expression in HeLa cell line by modified U1 snRNA
13:40
00:20:00
Wykład
Halina M. Waś
Role of HO-1 in chemically induced carcinogenesis in mice
14:30
Sesja plakatowa
14:30
#P5.1
Poster
Karol Jelonek
Polymorphism of DNA repair genes as a cancer risk factor; comparison between head and neck squamous cell carcinoma and colon cancer
14:30
#P5.2
Poster
Urszula Lewandowska
The role of WWOX in normal and pathological cell metabolism
14:30
#P5.3
Poster
Justyna K. Broniarczyk
Decreased level of TSG101 expression in epithelial cells at different stages of cervical cancer development is presumably not regulated by epigenetic modifications.
14:30
#P5.4
Poster
Katarzyna A. Szołtysek
Expression of the YEATS protein family in human cancer tissues.
14:30
#P5.5
Poster
Małgorzata Presler
Reduced expression of the ZAC mRNA in bladder cancer
14:30
#P5.6
Poster
Anna Krześlak
Expression and subcellular distribution of Akt1 in thyroid lesions
14:30
#P5.7
Poster
Jarosław Paluszczak
Modulation of the activity of DNA methyltransferases by plant phenolic compounds
14:30
#P5.8
Poster
Ludmiła Węglarz
The influence of phytic acid on NFκB expression in human colon cancer cells
14:30
#P5.9
Poster
Beata Parfiniewicz
Expression of genes of tumor necrosis factor -α and its receptors in colon cancer Caco-2 cells treated with inositol hexaphosphate
14:30
#P5.10
Poster
Małgorzata Kapral
Expression of matrix metalloproteinase 2 and matrix metalloproteinase 9 in laryngeal squamous cell carcinoma
14:30
#P5.11
Poster
Małgorzata Wolańska
Matrix metalloproteinases and their inhibitors of human leiomyoma in various stages of tumor growth.
14:30
#P5.12
Poster
Monika Mach
The changes of actin cytoskeleton triggered by cofilin and gelsolin are correlated with high metastatic potential of human colon adenocarcinoma cells
14:30
#P5.13
Poster
Agata Radwańska
Vinculin distribution accompanying to lumican-induced actin reorganization in human melanoma A375 cells
14:30
#P5.14
Poster
Jadwiga Snarska
Activity of α-fucosidase in serum and urine of smoking patients with colon adenocarcinoma.
14:30
#P5.15
Poster
Jan Stec
Effect of benzo(α)pyrene and aflatoxin B1 on sheep lymphocytes infected with bovine leukemia virus
14:30
#P5.16
Poster
Monika A. Pietrowska
Analyses of lymphocyte radiosensitivity in vitro for identification of predictive biomarkers of early response to radiotherapy in head and neck cancer patients
14:30
#P5.17
Poster
Robert Nowak
The sensitivity of immortalized hybrid endothelial-cancer cells EA.hy926 to UVC radiation in comparison with human promyelocytic leukaemia HL60 cells
14:30
#P5.18
Poster
Ewa Chodurek
The thermochemolysis of melanins isolated from melanoma malignum
14:30
#P5.19
Poster
Magdalena Łuczak
Application of 2-D electrophoresis and MALDI-TOF mass spectrometry for proteomic analysis of human acute myeloid leukemia cells
14:30
#P5.20
Poster
Łukasz Marczak
MALDI-TOF mass spectrometry analysis of blood serum proteins for the preparation for breast cancer biomarker discovery
14:30
#P5.21
Poster
Leszek Szmigiero
The effect of introduction of a formamidino group to the molecule of doxorubicin on its biological properties
14:30
#P5.22
Poster
Dorota Kostrzewa-Nowak
The role of bioreductive activation of idarubicin in the cytotoxic activity against leukaemia HL60 sensitive cell line and its multidrug resistant sublines
14:30
#P5.23
Poster
Agnieszka A. Maruszewska
The effect of antitumour agents, vincristine and doxorubicin, on non-enzymatic and enzymatic NADPH oxidation stimulated by pyridinium salts
14:30
#P5.24
Poster
Kamila Siedlecka
Resveratrol and apoptosis in MOLT-4 human leukemia cells
14:30
#P5.25
Poster
Iwona Mitrus
Use of conjugate of paclitaxel with PGA in melanoma tumour therapy in mice
14:30
#P5.26
Poster
Ryszard Smolarczyk
Combination of anticancer peptide (CAMEL) with immunotherapy in B16(F10) murine melanoma tumor therapy
14:30
#P5.27
Poster
Andrzej Smagur
New chimeric protein ABRaA-VEGF
121
is selectively cytotoxic towards cells overexpressing VEGFR2 (KDR) and inhibits growth of primary tumors.
© 1998-2024
pielaszek research
, all rights reserved
Powered by the
Conference Engine